Modeling healthcare quality: life expectancy SURS in the G7 countries and Korea

Firl, Daniel J. (2011): Modeling healthcare quality: life expectancy SURS in the G7 countries and Korea.

Abstract

In this study I have made efforts towards investigating healthcare in two arenas. First, can a model with life expectancy as a proxy for healthcare quality be used to objectify the study of efficiency in the G7 countries and Korea? Table 1 and the results section have illuminated many factor variables which vary between countries and characterize the environments in which different healthcare systems have developed. The analysis also illuminates an inherent structural difference in the mechanism of delivering healthcare throughout the developed world. Secondly, can these aggregate data be used to show us anything new about the studies performed by Peter Zweifel and Friedrich Breyer? Did the SISYPHUS Syndrome disappear in the early 1990s as Zweifel suggested in 2002? No, in Table 2 I have demonstrated through SURS that over the time period 1990-2009 there are clear statistically significant SISYPH variables in at least Canada, Germany, Korea, and Britain. Lastly, can I confirm Breyer’s model of HCE in Germany and can it be useful in other countries? Yes to extent possible the methodologies were replicated in a SURS fashion in an effort to simultaneously test and examine different variables in different countries. I was unable to confirm the results of Breyer in his 2011 examination of the sickness fund members for Germany. However, I was able to offer primitive characterizations of the other G7 countries and Korea and how their HCE move.

• Item Type: MPRA Paper
• Language: English
• Keywords: healthcare expenditures ; healthcare factor variables ; sisyphus syndrome
• Subjects: I - Health, Education, and Welfare > I1 - Health > I11 - Analysis of Health Care Markets; I - Health, Education, and Welfare > I1 - Health > I12 - Health Behavior; I - Health, Education, and Welfare > I1 - Health

References

Breyer, F., N. Lorenz and T. Niebel (2011), Population Ageing and Health Care Expenditures: The Role of Life Expectancy, Working Paper

Busse, R., J. Schreyogg and K.D. Henke (2005), Regulation of Pharmaceutical Markets in Germany: Improving Efficiency and Controlling Expenditures?, International Journal of Health Planning and Management20(4), 329-349.

Congressional Budget Office, Cost Estimate of H.R. 4872, Reconciliation Act of 2010, Mar. 20, 2010, http://www.cbo.gov/doc.cfm?index=11379.

Fuchs, V.R (1984), Though Much is Taken: Reflections on Aging, Health and Medical Care, MilbankMemorial Fund Quarterly/Health and Society 61, 143-166.

Lee, S.J. et al (2009), Functional Limitations, Socioeconomic Status and All-Cause Mortality in Moderate Drinkers, Journal of the American Geriatric Society. 57(6), 955-962.

Light, D.W. (2003), Universal Health Care: Lessons from the British Experience, American Journal of Public Health 93, 25-30.

Roland Berger Strategy Consultants (2007), Trends in European Health Care: How to Create Value in a Dynamic Environment, Published Study.

Seshamani, M. and A. Gray (2004), Ageing and Health-Care Expenditure: The Red Herring Argument Revisited, Health Economics 13, 303-314.

Stearns, S.C. and E.C. Norton (2004), Time to Include Time to Death? The Future of Health Care Expenditure Predictions, Health Economics 13, 315-327.

Werblow, A., S. Felder and P. Zweifel (2007), Population Ageing and Health Care Expenditure: a School of ‘Red Herrings’?, Health Economics 146, 1109-1127.

Zweifel, P., S. Felder and M. Meier (1999), Ageing of Population and Health Care Expenditure: A ‘Red Herring’?, Health Economics 8, 485-496.

Zweifel, P., S. Felder and A. Werblow (2004), Population Ageing and Health Care Expenditure:New Evidence on the ‘Red Herring’, Geneva Papers on Risk and Insurance: Issues and Practice. Special Issue on Health Insurance 29 (4), 653-667.